Contrast Media Injectors Market Is Expected To Touch New Landmark Of $1.4 Billion By 2025: Grand View Research, Inc.

Contrast Media Injectors Market Is Expected To Touch New Landmark Of $1.4 Billion By 2025: Grand View Research, Inc.

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The global contrast media injectors market size was estimated at USD 882.1 million in 2016 and In the application segment, interventional cardiology is projected grow at the highest rate during the forecast period.

The global contrast media injectors market is expected to reach USD 1.4 billion by 2025, growing at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive surgical procedures is a major factor expected to boost the market during the forecast period. These devices assist surgeons in accurate insertion of contrast agents with reduced human errors, thus increasing the accuracy and efficiency of surgical procedures. They play a crucial role in Intraoperative Computed Tomography (iCT), Intraoperative Magnetic Resonance Imaging (iMRI), and interventional cardiology. Availability of advanced injector systems for diagnosis and intraoperative imaging has boosted adoption of these systems. For instance, Medrad Stellant CT injection system integrated with Certegra Workstation provides high efficiency and accuracy in CT imaging.

U.S. contrast media injectors market by product, 2014-2025 (USD million)

Technological advancements, such as automated contrast media injectors and double-head injectors, are also among major factors supporting the growth of the market. Automated contrast media injectors provide improved patient safety, accuracy, and enhance image quality. Also, double-head injectors allow a large and rapid initial bolus of contrast, which is required in several imaging procedures. For instance, in cardiac CT, a fast injection is required for imaging of both sides of the ventricular septum to identify septal thickness, shunts, and enlarged ventricles. Delivery of contrast media is more efficient and controlled with a dual-head injector.

Access Full Insight:

Further Key Findings From the Report Suggest:

  • CT injector systems segment was the largest revenue-generating segment of the market in 2016 owing to availability of technologically advanced products and their widespread application for disease diagnosis and image-guided surgeries

  • The single head injectors segment accounted for the largest revenue share in 2016 and is expected to maintain its dominance throughout the study period

  • In the application segment, interventional cardiology is projected grow at the highest rate during the forecast period because of rising prevalence of cardiac diseases, such as coronary artery disease, heart valve disease, and peripheral vascular disease

  • In 2016, hospitals dominated the contrast media injectors market in terms of revenue because of an increase in the number of hospital admissions of patients suffering from cancer, neurological disorders, and cardiovascular diseases

  • The North America contrast media injectors market held the largest revenue share in 2016 and is projected to maintain its dominance during the forecast period owing to well-established healthcare infrastructure

  • Some of the major players are Bayer HealthCare LLC; Guerbet Group; Bracco Group; Medtron AG; GE Healthcare; Nemoto Kyorindo Co., Ltd.; Ulrich GmbH & Co. KG; VIVID IMAGING; Sino Medical-Device Technology Co., Ltd.; and APOLLO RT Co. Ltd.

Have Any Query? Ask Our Experts @

Grand View Research has segmented the global contrast media injectors market on the basis of product, type, application, end use, and region:

Product Outlook (Revenue, USD Million; 2014 – 2025)

  • Injector Systems

    • CT injector systems

    • MRI injector systems

    • Cardiovascular/angiography injector systems

  • Consumables

    • Tubing

    • Syringe

    • Others

Type Outlook (Revenue, USD Million; 2014 – 2025)

  • Single Head Injectors

  • Dual-Head Injectors

  • Syringeless Injectors

Application Outlook (Revenue, USD Million; 2014 – 2025)

  • Radiology

  • Interventional Cardiology

  • Interventional Radiology

End-Use Outlook (Revenue, USD Million; 2014 – 2025)

  • Hospitals

  • Diagnostics Centers

  • Ambulatory Surgery Centers

Regional Outlook (Revenue, USD Million; 2014 – 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

    • Saudi Arabia

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

For more information:

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States